The early parenteral and late oral administration of<unk><unk> s is indicated in STEMI patients who do not exhibit signs or symptoms of either congestive heart failure or cardiogenic shock.
ST elevation myocardial infarction beta blocker therapy
ST elevation myocardial infarction nitrate therapy
ST elevation myocardial infarction calcium channel blocker therapy
ST elevation myocardial infarction aspirin therapy
ST elevation myocardial infarction thienopyridine therapy
ST elevation myocardial infarction fibrinolytic therapy
ST elevation myocardial infarction anticoagulant and antithrombotic therapy
ST elevation myocardial infarction reperfusion therapy